Tumor-Agnostic Therapies and the Future of HER2 in Oncology

Labcorp, Rebecca Previs, Heidi Ko, HER2, NGS, precision oncology, tumor agnostic, breast cancer, gastric cancer, biomarker, ERBB2, IHC, FISH, biomarker

What tumor-agnostic approvals mean for HER2, NGS, and precision oncology — and how they’re changing treatment across cancer types.

Jun 8^th • 20 mins listen

Navigating the Future of CDXs in Oncology

Rebecca Previs, Dawn McHugh, Labcorp, precision oncology, companion diagnostics, CDx, biomarker, precision medicine

CDX expert Dawn McHugh joins Dr. Rebecca Previs to unpack the role of companion diagnostics in precision oncology and the future of cancer care.

Feb 18^th • 26 mins listen

Season 2, Episode 21: A Century of X-Rays with Margaret Yu

In this powerful episode of the Pharmaverse Podcast, host Michael Pietrack sits down with Dr. Margaret Yu, Chief Medical Officer at ARTBIO, an oncology company leading the charge in Radioligand Therapy (RLT) to revolutionize cancer care. Dr. Yu unpacks the 130-year history of radiation in medi…

Oct 27^th • 20 mins listen